Furthermore, IHC analyses demonstrated markedly elevated expression of CD31, enhanced microvascular outgrowth and increased MVD in Bmi-1-overexpressing gliomas, as opposed to those Bmi-1-knockdown gliomas (P<0.05, Figure 4A). This evidence concerns the gene BMI1 and central nervous system cancer.